One in three Canadians are currently living with obesity, and in 10 years, that number is going to change to about 50 per cent, so this is really an opportunity for policymakers to take action. LISTEN | WHO conditionally recommends GLP-1 drugs for obesity: The WHOs first conditional recommendation advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests interventions like a healthy diet and physical activity to be offered alongside the medicines
The subsequent activation of the inflammasome can be initiated by diverse cytoplasmatic DAMPs, but also, e.g., by extracellular ATP (eATP)
You can dig deeper into the research behind semaglutide's real-world results
Au HCT, Zheng YJ, Le GH, Wong S, Teopiz KM, Kwan ATH, et al